The retention medical therapy medicine null of kidney

摘要

PURPOSE:To obtain the titled preparation containing lactitol as an active ingredient. CONSTITUTION:Lactitol (4-beta-D-galactopyranosyl-D-sorbitol) as an active ingredient is blended with a carrier (e.g. lactose, starch, dextrin, white sugar, crystalline cellulose, kaolin, calcium carbonate, talc, calcium stearate, etc.) to give a conservative treatment agent for renal insufficiency. The agent is a drug which reduces methylguanidine in blood, promotes excretion of urea and creatinine, has inhibitory action on production of ammonia, etc., and on intestine absorption and shows progression retarding effects on renal insufficiency, progress suppressing effect on renal insufficiency, retarding effects on blood hemodialysis introduction period in renal insufficiency, improving and suppressing effects on renal function reduction in renal insufficiency, suppressing effects on occurrence of uremia. A dose is 20-40g/day/person in the case of oral administration. Tablet, film tablet, capsule, powder, granule, injection, etc., may be cited as the dosage form.